Key Points
- Grigorios Siokas, Cosmos Health's CEO, purchased 168,472 shares on Dec. 15 at an average price of $0.42 (about $70,758), bringing his direct holdings to 6,628,457 shares and representing a 2.61% increase after multiple recent buys in November.
- Cosmos Health is a small-cap firm (market cap ~ $17.5M) with weak recent results — quarterly EPS of ($0.17) missed estimates, negative return on equity and net margin — and the stock carries an average analyst rating of Sell.
- Institutional activity includes Citadel Advisors boosting its stake by 133.1% to 225,507 shares, and overall institutional ownership stands at about 12.61%.
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas purchased 168,472 shares of the company's stock in a transaction that occurred on Monday, December 15th. The stock was bought at an average price of $0.42 per share, for a total transaction of $70,758.24. Following the transaction, the chief executive officer directly owned 6,628,457 shares in the company, valued at $2,783,951.94. This trade represents a 2.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Friday, November 28th, Grigorios Siokas acquired 76,360 shares of Cosmos Health stock. The shares were bought at an average cost of $0.64 per share, with a total value of $48,870.40.
- On Tuesday, November 25th, Grigorios Siokas acquired 55,732 shares of Cosmos Health stock. The shares were bought at an average cost of $0.63 per share, with a total value of $35,111.16.
- On Friday, November 21st, Grigorios Siokas bought 56,080 shares of Cosmos Health stock. The stock was bought at an average price of $0.68 per share, for a total transaction of $38,134.40.
- On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The stock was bought at an average cost of $0.62 per share, for a total transaction of $31,815.30.
- On Wednesday, November 19th, Grigorios Siokas purchased 61,614 shares of Cosmos Health stock. The shares were bought at an average cost of $0.65 per share, with a total value of $40,049.10.
Cosmos Health Stock Performance
NASDAQ:COSM opened at $0.50 on Wednesday. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.99 and a quick ratio of 0.84. The firm has a market cap of $17.53 million, a price-to-earnings ratio of -0.67 and a beta of 5.34. The firm's fifty day moving average price is $0.76 and its 200 day moving average price is $0.72. Cosmos Health Inc. has a 1-year low of $0.28 and a 1-year high of $1.32.
Cosmos Health (NASDAQ:COSM - Get Free Report) last announced its quarterly earnings data on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.16). Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%.The firm had revenue of $17.11 million for the quarter, compared to analysts' expectations of $16.40 million. On average, sell-side analysts expect that Cosmos Health Inc. will post -0.78 EPS for the current year.
Analysts Set New Price Targets
Several research firms have issued reports on COSM. Wall Street Zen upgraded Cosmos Health to a "hold" rating in a research report on Saturday, September 20th. Weiss Ratings restated a "sell (d-)" rating on shares of Cosmos Health in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of "Sell".
Get Our Latest Stock Analysis on Cosmos Health
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC grew its stake in shares of Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 133.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 225,507 shares of the company's stock after acquiring an additional 128,776 shares during the period. Citadel Advisors LLC owned about 0.65% of Cosmos Health worth $250,000 at the end of the most recent reporting period. 12.61% of the stock is owned by institutional investors and hedge funds.
About Cosmos Health
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
